Winclove Probiotics, established in Amsterdam, the Netherlands, has been specialising in research, development and manufacturing of probiotic formulations for over 25 years. In close collaboration with business partners, research institutes and university hospitals we develop evidence-based, indication-specific probiotics for a variety of indications. Our probiotic formulations enable people worldwide to improve their health in a natural way.
Our expertise lies in developing evidence-based probiotic formulations for specific health indications. Wherever an imbalance in the microbiota causes problems, we seek for an optimal way to restore the microbial balance with targeted probiotics.
Key strengths of our probiotic formulations are:
We offer probiotic solutions for a broad range of microbiota-based disturbances. Our probiotics are focused on, but not limited to, the following health indications:
Formulating effective probiotics of the highest quality demands expert knowledge in each and every step of the probiotic development process. Probiotic effectiveness depends in a significant part on the condition and activity of the bacteria. Therefore, a large part of our research focuses on ingredients that improve the wellbeing of our friendly microbes. For each probiotic formulation we select specific active nutrients depending on the bacteria in the formulation. These ingredients are focused on:
The sum of these ingredients is called PROBIOACT® Technology, short for PROBIOtic ACTivity. PROBIOACT® provides bacteria with specific protection and nutrition and ensures bacterial viability and metabolic activity for a highly effective probiotic.
Winclove is currently presented through over 60 partners selling a broad range of probiotic formulations, under private label, worldwide. We are always looking for new partners to join us in exploring host-microbiome interactions, developing novel technologies, or marketing one of ours, or customised, probiotic formulations.